Investigation of a new therapeutic strategy to lower mutant protein in SCA3 / MJD
2021/41/B/NZ2/03881
Keywords
Descriptors
- NZ2_001: Genetyka molekularna
- NZ2_003: Proteomika
- NZ3_005: Neurobiologia molekularna
Panel
NZ2 – Genetics, genomics: molecular genetics, genomics, proteomics, bioinformatics, systems biology, genetic epidemiology
Host institution
Instytut Chemii Bioorganicznej PAN
Voivodeship: wielkopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 5
Call
OPUS 21 – announced on 2021-03-15
- Amount awarded
- 2 424 140 PLN
- Project start date
- 2022-02-01
- Project end date
- 2028-07-31
- Project duration
- 78 months (the same as in the proposal)
- Project status
- Pending project
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publication in academic press/journals (2)
-
Impaired interactions of ataxin-3 with protein complexes reveals their specific structure and functions in SCA3 Ki150 model
- Authors:
- Piotr Piasecki, Kalina Wiatr, Milosz Ruszkowski, Łukasz Marczak, Yvon Trottier, Maciej Figiel
- Academic press:
- Frontiers in Molecular Neuroscience (year: 2023, volume: 16, pages: 1122308), Publisher: Frontiers Media SA
- Status:
- Published
- DOI:
- 10.3389/fnmol.2023.1122308 – link to the publication
-
Selective transduction of cerebellar Purkinje and granule neurons using delivery of AAV-PHP.eB and AAVrh10 vectors at axonal terminal locations
- Authors:
- Magdalena Surdyka, Ewelina Jesion, Anna Niewiadomska-Cimicka, Yvon Trottier, Żaneta Kalinowska-Pośka and Maciej Figiel
- Academic press:
- Frontiers in Molecular Neuroscience (year: 2022, volume: 15, pages: 947490), Publisher: Frontiers
- Status:
- Published
- DOI:
- 10.3389/fnmol.2022.947490 – link to the publication